| Quant Healthcare Fund Datagrid | ||||||
|---|---|---|---|---|---|---|
| Category | Pharma Fund | |||||
| BMSMONEY | Rank | N/A | ||||
| Rating | N/A | |||||
| Growth Option 04-12-2025 | ||||||
| NAV | ₹15.11(R) | -0.4% | ₹15.71(D) | -0.39% | ||
| Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
| Lumpsum | Regular | -7.34% | -% | -% | -% | -% |
| Direct | -5.81% | -% | -% | -% | -% | |
| Nifty Pharma TRI | 3.12% | 21.61% | 14.04% | 15.04% | 7.75% | |
| SIP (XIRR) | Regular | 0.82% | -% | -% | -% | -% |
| Direct | 2.47% | -% | -% | -% | -% | |
| Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
| Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
| Fund AUM | As on: 30/06/2025 | 403 Cr | ||||
| Top Pharma Fund | |||||
|---|---|---|---|---|---|
| Fund Name | Rank | Rating | |||
| Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | - | ||||
| Sbi Healthcare Opportunities Fund | - | ||||
NAV Date: 04-12-2025
| Scheme Name | NAV | Rupee Change | Percent Change |
|---|---|---|---|
| quant Healthcare Fund - Growth Option - Regular Plan | 15.11 |
-0.0600
|
-0.4000%
|
| quant Healthcare Fund - IDCW Option - Regular Plan | 15.11 |
-0.0600
|
-0.4000%
|
| quant Healthcare Fund - Growth Option - Direct Plan | 15.71 |
-0.0600
|
-0.3900%
|
| quant Healthcare Fund - IDCW Option - Direct Plan | 15.71 |
-0.0600
|
-0.3900%
|
Review Date: 04-12-2025
Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.
Data Source: www.amfiindia.com
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | -1.52 | 2.81 |
-1.01
|
-1.79 | -0.09 | 10 | 12 | Poor |
| 3M Return % | -0.42 | 4.79 |
0.09
|
-1.09 | 1.13 | 11 | 13 | Average |
| 6M Return % | -1.94 | 7.96 |
4.26
|
-1.94 | 8.01 | 13 | 13 | Poor |
| 1Y Return % | -7.34 | 3.12 |
-0.50
|
-7.34 | 5.07 | 13 | 13 | Poor |
| 1Y SIP Return % | 0.82 |
3.34
|
-25.71 | 10.70 | 12 | 13 | Average |
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | -1.39 | 2.81 | -0.91 | -1.66 | -0.01 | 10 | 12 | Poor |
| 3M Return % | -0.02 | 4.79 | 0.41 | -0.84 | 1.47 | 10 | 13 | Average |
| 6M Return % | -1.15 | 7.96 | 4.93 | -1.15 | 8.94 | 13 | 13 | Poor |
| 1Y Return % | -5.81 | 3.12 | 0.79 | -5.81 | 6.47 | 13 | 13 | Poor |
| 1Y SIP Return % | 2.47 | 4.69 | -24.55 | 12.63 | 12 | 13 | Average |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
| Date | Quant Healthcare Fund NAV Regular Growth | Quant Healthcare Fund NAV Direct Growth |
|---|---|---|
| 04-12-2025 | 15.1108 | 15.713 |
| 03-12-2025 | 15.0936 | 15.6945 |
| 02-12-2025 | 15.1711 | 15.7744 |
| 01-12-2025 | 15.2634 | 15.8696 |
| 28-11-2025 | 15.3027 | 15.9084 |
| 27-11-2025 | 15.3181 | 15.9237 |
| 26-11-2025 | 15.3298 | 15.9352 |
| 25-11-2025 | 15.0708 | 15.6653 |
| 24-11-2025 | 15.1009 | 15.6959 |
| 21-11-2025 | 15.2529 | 15.8518 |
| 20-11-2025 | 15.4199 | 16.0247 |
| 19-11-2025 | 15.5001 | 16.1073 |
| 18-11-2025 | 15.5536 | 16.1622 |
| 17-11-2025 | 15.5728 | 16.1814 |
| 14-11-2025 | 15.4866 | 16.0898 |
| 13-11-2025 | 15.4735 | 16.0754 |
| 12-11-2025 | 15.4807 | 16.0822 |
| 11-11-2025 | 15.3168 | 15.9113 |
| 10-11-2025 | 15.3813 | 15.9775 |
| 07-11-2025 | 15.1749 | 15.7611 |
| 06-11-2025 | 15.1422 | 15.7264 |
| 04-11-2025 | 15.344 | 15.9346 |
| Fund Launch Date: 17/Jul/2023 |
| Fund Category: Pharma Fund |
| Investment Objective: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends. |
| Fund Description: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends. |
| Fund Benchmark: BSE Healthcare TRI |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.